FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality.

Parkinson’s Dementia May Be Less Common Than Once Thought

Parkinson’s disease dementia may occur less frequently than previously thought. The estimated risk of dementia increased with disease duration. Age, male sex, and lower educational

August 8, 2024

New discovery could lead to a treatment for visceral leishmaniasis

A discovery by Simona Stäger’s team could help come up with a treatment to the most serious form of leishmaniasis.

May 21, 2024

Lexeo Therapeutics and Abivax seek Nasdaq listings in shrinking window for biotech IPOs pre-Thanksgiving

The gene therapy startup Lexeo Therapeutics and inflammatory disease biotech Abivax filed paperwork to go public Friday afternoon, as the pre-Thanksgiving IPO window shrinks and a

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.